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ABSTRACT 
 
Mono-allelic expression of H19 and Igf2 depends on parental-specific methylation of an 
imprinting control region (ICR). Although CTCF sites maintain the absence of DNA 
methylation on maternal ICRs after fertilization, some Beckwith-Wiedemann patients 
showed maternal ICR methylation that correlated with mutations in one of the pair of 
octamer binding sites within the ICR. Using a tissue culture system, we found that both 
octamers were required for transgene hypomethylation in F9 cells and that Oct4 was 
present at the endogenous ICR. In addition, each of the octamers is flanked by a sequence 
that allowed cooperative binding of Oct4 and Sox2 in vitro. To determine at which 
developmental stage the octamers regulate ICR methylation, we created a knock-in 
mouse with mutations in the ICR that eliminate Oct4 binding. Maternal transmission of 
this mutant allele resulted in partial methylation of the maternal ICR in somatic tissues 
but had little effect on imprinted expression of H19 and Igf2. Although a subset of 
oocytes showed partial methylation of the mutant ICR, maternally inherited mutant 
alleles were unmethylated in blastocysts, indicating that the methylation acquired during 
oogenesis was not a stable imprint. Absence of mutant ICR methylation in female 
primordial germ cells regardless of parental origin demonstrated that the octamers are not 
required for imprint erasure but protect the ICR from de novo methylation during 
oogenesis. These findings provide the first direct evidence that octamers are required for 
hypomethylation of an endogenous ICR. 
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CHAPTER 1: INTRODUCTION 
 
GENOMIC IMPRINTING 
 
Development of multicellular organisms depends on the transmission and 
inheritance of stable gene expression profiles that result from differential DNA 
methylation and histone modifications. These reversible “epigenetic” marks have a 
profound effect on the chromatin architecture and accessibility of genes to cis- and trans-
acting regulatory elements without changing the underlying genetic sequence [6,10]. 
Therefore, while the individual cells comprising an organism generally share a common 
genome, they acquire unique epigenomes as a means of establishing and maintaining the 
differential expression of genes associated with disparate cell structures and functions 
(reviewed in [7,47]). During mammalian gametogenesis divergent pathways of cellular 
differentiation for sperm and oocyte result in epigenomic heterogeneity that renders 
maternal and paternal genomes functionally non-equivalent [79,119,120]. Parental 
specific epigenetic marks or ‘imprints’ established in the different germ lines result in 
unequal expression of autosomal alleles that is essential for normal organism 
development. The requirements for establishing and maintaining these imprints and the 
mechanism by which epigenetic modification regulate imprinted gene expression has 
been an active area of research for more than two decades. 
 
 To date 144 imprinted mouse genes have been identified from uniparental 
disomies of whole chromosomes and uniparental duplications of selected chromosome 
regions [139]. However, this number is likely to increase as researchers begin validating 
some of the more than 1300 loci showing parent-of –origin effects in RNA-seq 
experiments performed on embryonic and adult brain [34]. More than 80% of genes 
whose imprinted expression has been independently validated are clustered in genomic 
regions containing two or more imprinted genes and more than 40 of these genes are 
distributed between 7 well characterized genomic clusters (Gnas on chr:2; Kcnq1, Pws/As 
and Igf2 on chr7; Grb10 on chr11, Dlk1 on chr12; Igf2r on chr17) [3]. Imprinted genes 
within a given cluster can be spread over as much as 2-3 Mb, as is the case for the Pws/As 
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locus, but are regulated by a common imprinting control region (ICR) capable of 
influencing gene expression in cis over long distances [77]. At many of these loci, 
parental-specific epigenetic modifications to the ICR results in both activation and 
repression of different neighboring genes. Genes regulated in this way are said to be 
reciprocally imprinted as lack of the same imprint on the opposite parental allele reverses 
the expression profile. All 7 major clusters contain reciprocally imprinted genes, and 
except for Grb10, the imprints at their respective ICRs are associated with activate 
protein coding genes and an inactive noncoding RNA gene (ncRNA) [3].   
 
 Differential DNA methylation is a hallmark of the genetic imprints. Each ICR 
contains a differentially methylated region (DMR) that acquires methylation in only one 
of the germ lines. Mammalian DNA methylation involves a reversible covalent 
modification at the C-5 position of cytosine residues in CpG dinucleotides that is 
catalyzed by two distinct families of DNA methyltransferases (DNMTs) [8]. The 
DNMT3 family, which includes DNMT3a, DNMT3b and DNMT3L, is responsible for de 
novo methylation of CpGs, and the DNMT1 family, which includes DNMT1 and (an 
oocyte specific isoform) DNMTo, is responsible for maintaining CpG methylation [9]. 
Establishment of maternal germline specific methylation imprints requires both DNMT3a 
and the non-catalytically active DNMT3L [12,52,53]. Establishment of paternal imprints 
depends predominantly on DNMT3a and to a lesser extent on DNMT3L [9,52]. 
Maintenance of parental imprints following fertilization depends on oocyte derived 
DNMT1 and DNMT1o for the earliest cleavage stages and conceptus derived DNMT1 
for the rest of development [20,21]. Once established, the majority of methylation 
imprints are stably maintained in adult somatic cell lineages irrespective of the imprinted 
gene’s tissue-specific expression [141]. However, the mechanism by which ICRs recruit 
or inhibit DNMT and other epigenetic regulators as a means of establishing and 
maintaining parental imprints is not entirely clear.  
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ESTABLISHING IMPRINTS 
 
During gametogenesis, establishment of identical sex-specific methylation 
patterns on homologous chromosomes is preceded by genome wide erasure of 
methylation including imprints. By embryonic (E) day 13.5, CpG methylation in male 
and female primordial germ cells (PGCs) has been reduced to 16.3% and 7.8% 
respectively compared to 73.2% for the whole embryo [98]. This process of 
demethylation takes place from E7.5-12.5 and likely requires both active and passive 
mechanisms [103]. Transcription of DNMT3a, DNMT3b, DNMT1 recruitment factor 
UHRF1/NP45 and histone H3K9me2 methyltransferase GLP are repressed in PGCs 
shortly after lineage commitment (~E7.5) [61,108,109]. A second H3K9 
methyltransferase, G9a, is also repressed at ~E9.5 [108]. Consequently, PGCs show 
reduced genome wide methylation, including 50% demethylation of the H19 and Peg10 
imprinted genes, and significant loss of H3K9me2 by the time the cells have finished 
migrating to the genital ridge (~E10.5) [66,109]. Other imprinted genes, including Snrpn, 
Peg3 and Kcnq1ot1, are almost completely methylated at E11.5 but actively lose most of 
their methylation by E12.5. Activation-induced cytosine deaminase (AID) mediated 
deamination of cytosine to thymine followed by base excision repair (BER) is one 
possible mechanism for active demethylation in the germline [38,98]. However, AID-
deficient PGCs still have low levels of genomic methylation (~21%) possibly due the 
presence of compensatory deaminases or 5-methylcytosine (5mC) hydroxylases [103].  
 
 Sex-specific differential methylation at ICRs may result from different temporal 
expression profiles of de novo methyltransferases [14,115]. In the male germ line 
DNMT3a and DNMT3L expression resumes in diploid prospermatogonia at E14 and 
results in gradual CpG methylation until shortly after birth [63,104]. Both DNMT3s are 
required for complete methylation of retrotransposons and paternal ICRs and for 
spermatogonia to successfully complete meiosis [15,54]. DNMT3a and DNMT3L are 
also essential for maternal ICR methylation, but its expression in oocytes begins 
postnatally after which time meiotic recombination has already taken place [63,73]. The 
concomitant lack of cell divisions and prolonged high levels of DNMT3 in growing 
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oocytes likely contributes to dimorphic methylation patterns including the greater number 
of maternally methylated ICRs and the presence of non-CpG methylation in oocytes and 
not sperm [129]. 
 
Differences in pre- and post-meiotic chromatin architecture influence the 
accessibility of ICRs to DNMTs [14]. During meiosis there are global changes in histone 
composition and modifications including changes in H3K4 methylation that are required 
for DNA methylation at some imprinted loci [1,74]. DNMT3L has been shown to interact 
with H3 amino terminus and its binding is strongly inhibited by H3K4me [91]. The 
presence of this histone modification in male PGCs may therefore prevent ICR 
methylation of maternally imprinted genes. Moreover, the maternally expressed H3K4 
demethylase KDM1B is necessary for establishment of DNA methylation imprints at a 
subset of loci in oocytes [19]. In addition to H3K4 hypomethylation, repressive histone 
marks such H3K9 di/trimethylation, H4K20 trimethylation and heterochromatin protein 1 
(HP1) may be sufficient to initiating de novo ICR methylation by recruiting DNMTs 
through the KRAB box zinc-finger protein Zfp57 and other mediators[115,149] . The 
maternally methylated Snrpn ICR is unmethylated in oocytes deficient in Zfp57, but it 
reacquires methylation via a Zfp57 dependent mechanism in the zygote suggesting the 
existence of a chromatin specific initiator of methylation [70].  
 
Differential expression of male and female specific trans-acting factors have been 
found essential for establishing imprints at only a few loci. In addition to the maternally 
expressed KDM1B, paternal expression of MILI and MIWI2 are required for piRNA 
dependent methylation of Rasgrf1 ICR in spermatogonia [136]. A paternally expressed 
paralog of CTCF, CTCFL/BORIS, has also been proposed to facilitate methylation at the 
H19/Igf2 ICR through the recruitment of a complex involving the H4 methyltransferase 
PRMT7 and DNMT3s [48]. However, the establishment of normal methylation patterns 
in male PGCs with ICRs containing mutant CTCFL binding sites indicates this 
mechanism is not essential [106].  
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Parental-specific protection of ICRs from de novo methylation in PGCs is equally 
important for inheritance of imprinted traits but its mechanics are even less well 
understood. Unmethylated DMRs at ICRs can function as CpG islands (CGIs) which 
utilize cis-regulatory elements to promote a euchromatic state that is not conducive to 
DNA methylation. Five such elements, including two Oct and one Sox binding site, have 
been identified at the paternally imprinted Angelman syndrome ICR (AS-IC) which are 
required for ICR hypomethylation in oocytes [55]. A more universal mechanism of 
maintaining ICR hypomethylation may be through the CxxC finger protein, Cfp1, which 
is required for H3K4me enrichment at unmethylated CGIs [127]. Cfp1 binds specifically 
to unmethylated CpGs and associates with the H3K4 methyltransferase Setd1 [67,133]. 
 
MAINTAINING IMPRINTS 
 
The genome undergoes dynamic epigenetic modifications as the totipotent state of 
the zygote gives way to the progressively differentiated cells that will comprise either the 
extra-embryonic tissue or the adult organism. This process includes a wave of genome-
wide demethylation during cleavage followed by extensive de novo methylation during 
gastrulation [83,84,103]. Both of these events challenge allelic imprinting differences. 
DNA demethylation is initiated in the male pronuclei prior to the first cell division by 
TET dependent iterative oxidation of 5mC to 5-hydroxymethylcytosine (5hmC), 5-
formylcytosine (5fC), and finally 5-carboxylcytosine (5caC) [35,44]. Demethylation of 
both male and female chromosomes then proceeds through a passive replication-
dependent dilution of 5-cytosine moieties [45]. However, the maternal pronuclei and at 
least two paternal imprints at the Igf2/H19 and Rasgrf1 loci are protected from 5mC 
oxidation by the DNA binding protein PGC7/Dppa3/Stella [86,142]. PGC7/Stella also 
contributes to transcriptional silencing and chromatin condensation in late stage 
oogenesis, but how it is targeted specifically to methylation imprints and selected repeats 
and not the rest of the male pronucleus, which is ~ 80% methylated at CpGs, is unknown 
[72,103,135].  
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Imprints are also preserved by direct binding of Zfp57 to specific methylated 
DNA sequences post-fertilization and concomitant recruitment of KAP1 [70,99]. KAP1 
can in turn form complexes with UHRF1, DNMTs, repressive histone deacetylases 
(HDACs) and the histone methyltransferase SETDB1 all of which have been shown to 
localize at methylated ICRs [140,149]. At the H19 ICR, four of six Zfp57 consensus 
sequences, TGCCGC, partially overlap three CTCF binding sites [99]. The H19 ICR has 
been thoroughly investigated and a retrospective assessment of previous work is 
consistent with a possible role for Zfp57 in maintaining H19 ICR methylation. Deletions 
of CTCF and Zfp57 sites in mice reduced methylation on the paternally imprinted allele 
in somatic tissue while mutations inhibiting only CTCF binding had no effect on the 
paternal imprint [29,106]. Disruption of Zfp57 and CTCF sites in stably expressed H19 
ICR transgenes also indicated these sequences were required for methylation-dependent 
repression in specific cell types [17].  
 
The stability of many imprints in the preimplantation embryo likely depends on 
positive feedback loops that exist between DNA methylation and histone modifications 
[16,18,47]. Although most nucleosomes are replaced by protamines in sperm, the 
majority of methylation imprints are maternally derived and can be inherited with 
repressive chromatin [27]. H3K9 di/trimethylation, H4K20 trimethylation and sometimes 
heterochromatin protein 1 (HP1) show enrichment on alleles bearing methylation 
imprints while euchromatic histone modification such as H3K4 di/trimethylation and H3 
acetylation are absent [51,81,100,144]. The presence of H3K9me and H4K20me 
enrichment at most ICRs is methylation dependent [41]. Methylated DNA maintains 
these differential histone modifications through the activity of Zfp57, MeCP2, and other 
related methyl-CPG binding domain proteins (MBDs) which can recruit co-repressor 
complexes containing HDACs [32,50,87,149]. UHRF1 and DNMT1, which bind 
preferentially to hemimethylated DNA and are required for methylating newly 
synthesized strands, also recruit the H3K9 methyltransferases G9a and GLP 
[11,110,146]. Methylated H3K9 can then reinforce CpG methylation through UHRF1 or 
HP1 - Kap1 complex mediated recruitment of DNMTs [101,111,146].  
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 Mechanism required for preserving differential methylation at ICRs during 
genome wide remethylation likely depends on which parent the hypomethylated ICR was 
inherited. Rapid exchange of protamines with maternal histones during male pronuclear 
decondensation combined with histone acetylation and lack of repressive histone 
modifications following genome wide demethylation may create an unmethylated  default 
state for most paternal ICRs [132].  Alternatively, the unmethylated paternal ICR at the 
Kcnq1 cluster has been shown to retain nucleosomes with H3K4me in sperm [36]. 
Protection from de novo methylation may also depend on many of the same cis-
regulatory elements that insure hypomethylation of ICR in the germline. The H19/Igf2 
ICR has demonstrated the capacity to promote hypomethylation of transgenes in tissue 
culture in an Oct dependent manner similar to the AS-IC [42,55]. However, fundamental 
differences in chromatin architecture between gametes and the differentiating cells of the 
conceptus likely explain the requirements for different trans-regulatory factors. One such 
protein is CTCF which is required for hypomethylation of the maternal H19/Igf2 ICR in 
somatic tissue but not in oocytes [29,106].  
 
REGULATING TRANSCRIPTION 
  
 ICRs regulate mono-allelic expression of neighboring genes through two primary 
mechanisms which function in a tissue- and developmental–specific manner.[59].  The 
most common of which involves the establishment and maintenance of repressive 
heterochromatin either at a proximal promoter or at multiple promoters over long 
distances through a mechanism involving long ncRNAs [64]. ICRs are frequently located 
at promoters for ncRNAs and when methylated are capable of directly inhibiting their 
expression [13]. ICRs at the maternally imprinted Kcnq1 and Igf2r clusters are located at 
promoters for the respective ncRNAs Kcnqot1 and Airn which are only expressed from 
the paternally unmethylated alleles [75,76,114]. These ncRNAs functions in cis to repress 
paternal genes via transcription-mediated silencing or RNA-mediated silencing [94]. In 
the placenta Kcnqot1 silencing of imprinted genes largely depends on an RNA-dependent 
recruitment of both polycomb repressive complex 1 (PRC1) and G9a for respective 
methylation of H3K27 and HK9 and polycomb repressive complex 2 (PRC2) for 
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repressive H2AK119 monoubiquitination [125,131,134]. The placental-specific 
imprinted expression of Slc22a3 in the Igf2r cluster also requires G9a [82]. However, 
other genes at these loci which are ubiquitously imprinted in both the placenta and the 
embryo demonstrate different tissue specific requirements for PRC1 and 2 or G9a 
indicating the existence of alternative mechanisms of repression. Both ubiquitously 
imprinted Igf2r and Kcnq1 genes are partially overlapped by the respective ncRNA at 
their locus which is transcribed in an antisense direction and therefore potentially capable 
of direct interference. Alternatively, Airn may disrupt placental enhancers at the Igf2r 
locus thereby interfering with transcription of Slc22a3 [58].  
 
 The other primary mechanism by which imprinted genes are regulated involves 
establishment and maintenance of differential insulators via the zinc finger DNA binding 
protein CTCF [85]. CTCF has the capacity to mediate long range intra-chromosomal 
interaction by binding to distant sites and recruiting the cohesin complex which can unite 
the sites to form chromosomal loops [80,138]. This partitioning in turn facilitates or 
blocks the interaction of promoters with distant enhancers and can separate regions of 
active or repressed chromatin. Both the H19/Igf2 ICR, described in detail below, and the 
Rasgrf1 ICR functions as CTCF dependent enhancer blockers [5,40,145].  
 
THE H19/IGF2 LOCUS 
 
 Insulin like growth factor 2 (Igf2) and H19 were among the first imprinted genes 
discovered and their reciprocal expression has been extensively studied [2,4,24]. They are 
part of a cluster of four imprinted genes, including the insulin 2 (Ins2) gene and Igf2 anti-
sense (Igf2as) gene, located on mouse distal chromosome 7 and in shared synteny on 
human chromosome 11p15 [68,90]. Igf2 is one of only two paternally expressed 
imprinted genes that are required for viability of parthenogenetic embryos [60,143]. H19 
is a maternally expressed non-coding RNA that is not essential for development but may 
serve to modulate the expression of Igf2 and other imprinted genes in trans [33]. 
Increased Igf2expression resulting from paternal duplications, uniparental disomy (UPD) 
or maternal loss of imprinting results in a fetal overgrowth phenotype in mouse or a 
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pediatric overgrowth disorder in humans known as Beckwith-Wiedemann syndrome 
(BWS), which is also associated with a predisposition for tumor development [68,137]. 
In contrast, loss of paternal imprinting results in diminished or absent Igf2 expression and 
is frequently responsible for the intrauterine and postnatal growth retardation associated 
with Siver-Russel syndrome in humans [102]. 
 
 The mouse Igf2 cluster is spread over ~100 kb with a 72 kb intergenic region 
separating Igf2 and H19 (Fig.1a). An ICR located with the intergenic region ~2 kb 
upstream of H19 contains four CTCF binding sites that are required for imprinted 
expression at the locus [106]. CTCF binds to the unmethylated ICR and mediates cohesin 
complex dependent interactions with DMR 1 at Igf2 and the matrix attachment region 3 
(MAR3) on the maternal allele to form intra-chromosomal loops (Fig. 1b) [62,88,138]. 
These loops prevent shared enhancers from associating with Igf2 and create a boundary 
that separates an active chromatin region containing H19 from a repressive chromatin 
region containing Igf2 [113]. In addition to the physical boundary, CTCF contributes to 
Igf2 repression by interacting with Suz12 and recruiting PRC 2 to direct H3K27 
methylation at the Igf2 promoters [69]. In contrast, hypermethylation at the paternal ICR 
inhibits CTCF binding and prevents the formation of chromatin loops that block enhancer 
access to Igf2 [5,62]. The methylated ICR also represses H19 transcription both by 
facilitating H19 promoter methylation and through poorly defined cis-regulatory 
elements [43,128].     
 
PROJECT SUMMARY 
 
Differential ICR methylation is essential for imprinted H19/Igf2 expression. The 
focus of this project was to investigate the role of the conserved octamers identified by 
Hori et al. in establishing and/or maintaining the hypomethylated state of the ICR in vivo. 
In order to answer that question we first utilized a tissue culture based system to compare 
the effect of octamer and CTCF site mutations on acquisition and erasure of DNA 
methylation of stably incorporated ICR transgenes. Contrary to the requirements for 
CTCF in protecting the ICR from de novo methylation in mouse somatic cells, we found 
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that the octamers were the primary regulator of ICR transgene methylation [106]. 
Moreover, we determined that octamer mediated demethylation was dependent on 
flanking Sox binding sites and specific to F9 cells which express both Oct4 and Sox2 
pluripotency factors. Further characterization of the ICR Sox/Oct motifs using 
electromobility shift assay (EMSA) demonstrated that they cooperatively bind Oct4 and 
Sox2. Using a luciferase reporter assay we also discovered that the ICR Sox/Oct motifs 
can function as an Oct4/Sox2 dependent transcriptional activator. As a definitive test of 
octamer dependent regulation of ICR methylation at the endogenous locus, we created a 
knock-in mouse with mutant octamers. Analysis of ICR tissue-specific methylation and 
H19 and Igf2 allelic expression demonstrated that the octamers are required for protecting 
the maternal allele from de novo methylation in oocytes and somatic tissue but not for 
imprinted expression. 
 
11 
 
FIGURES 
 
 
 
Figure 1.  ICR dependent regulation of H19 and Igf2 imprinted expression in the mouse. (A) 
Maternal (top) and paternal (bottom) alleles are shown with their respective unmethylated (open lollipop) 
or methylated (closed lollipop) ICR and secondary DMRs. The unmethylated maternal ICR binds CTCF 
and establishes cohesin dependent chromatin loops that restrict localization of shared enhancers to the H19 
promoter (B). Methylation at the paternal ICR prevents CTCF dependent looping and provides downstream 
enhancers access to the Igf2 promoter. Mesodermal and endodermal enhancers are represented by light and 
dark hash mars respectively. The matrix attachment region, MAR3, is represented by a closed oval. The 
looping model is based on chromosome conformation capture (3C) analysis of neonatal liver [62]. 
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CHAPTER 2: OCT4 AND SOX2 REGULATE 
METHYLATION AT THE IGF2/H19  
IMPRINT CONTROL REGION  
 
INTRODUCTION 
 
Genomic imprinting is an epigenetic phenomenon that results in unequal 
expression of genes based on their parent of origin. Maternal and paternal alleles are 
distinguished by differentially methylated regions (DMRs) which acquire unique gamete 
specific DNA methylation and chromatin modifications. Once established, these parental 
-specific imprints are maintained in somatic cell linages where they direct expression and 
repression of neighboring imprinted genes either directly through cis-regulatory elements 
or indirectly by driving the expression of anti-sense regulatory RNAs and/or mediating 
long range chromatin interaction between promoters and distal enhancers.     
 
A DMR at the imprint control region (ICR) upstream of the H19 gene on mouse 
chromosome 7 and in shared synteny on human chromosome 11P15 (IC1) coordinates 
the reciprocal expression of H19 and Igf2 by controlling access to shared enhancers. The 
maternal ICR is hypomethylated and functions as a CTCF dependent chromatin boundary 
that facilitates interaction of the H19 promoter with downstream enhancers through the 
formation of Cohesin dependent intra-chromosomal loops [62,88,95].  Hypermethylation 
of the paternal ICR represses H19 expression and blocks CTCF binding which results in 
an alternative looping arrangement that facilitates interaction of the enhancers with the 
Igf2 promoter. Deletion of the ICR in mice results in a loss of parental-specific 
partitioning of promoters and enhancers and biallelic expression of H19 and Igf2 [30]. In 
humans, inheritance of maternally methylated IC1 accounts for 10% of cases of 
Beckwith-Wiedemann Syndrome (BWS) – a fetal overgrowth syndrome that also 
includes an increased risk of childhood tumors[137]. Analysis of maternally methylated 
alleles from BWS cell lines detected a loss of CTCF-Cohesin binding at the ICR and 
chromatin architecture similar to the paternally imprinted allele.[89] 
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In addition to its insulator function, CTCF has been shown to protect the maternal 
ICR in somatic cells from de novo methylation during embryogenesis [31,106,123].  Loss 
of CTCF binding at one or more of the four binding sites in the  mouse ICR results in 
methylation of the mutant maternal allele and biallelic expression of Igf2[29,93,106]. 
Mutations that allow CTCF to bind methylated paternal ICRs have also shown CTCF 
capable of facilitating demethylation of the paternal allele in mouse somatic tissue [28].    
However, the mechanism of demethylation and the involvement of other cis-regulatory 
elements within the ICR are unknown. CTCF binding is not required for erasure of 
paternal imprints in mice primordial germ cells (PGCs) or protection of the ICR from de 
novo methyltransferases during postnatal methylation imprint establishment in 
oocytes[29,106,123].     
 
A conserved pair of Sox-Oct motifs located between CTCF sites 2 and 3 in mice 
and in both A repeats of the human IC1 have been suggested as possible regulators of 
ICR methylation. N. Hori, et al. demonstrated that Oct4 binding sites were required for 
demethylation of partially methylated ICR transgenes in a mouse embryonic carcinoma 
cell line [42]. Analysis of genomic ChIP-seq data for Oct4 and Sox2 has also found the 
pluripotency factors enriched at the endogenous ICR in mouse embryonic stem (ES) cells 
implying that they may play a role in establishment and or maintenance of maternal 
imprints [78].  Furthermore, all reported IC1 micro-deletions and point mutations 
associated with abnormal maternal ICR methylation in BWS patients have included the 
loss or disruption of Oct- and/or Sox2-binding sites[23,25,97,116,117]. Genetic 
alterations that only affect CTCF sites at the IC1 have not been reported for BWS.  
 
In this study we investigated the cooperative binding characteristics of Oct4 and 
Sox2 at the ICR and determined that cooperative binding is required at both Sox-Oct 
motifs for robust ICR transgene hypomethylation and octamer induced transcriptional 
activation in a murine embryonic carcinoma cell line. In contrast to Sox-Oct motifs, 
CTCF binding contributed little to ICR transgene demethylation. We also analyzed the 
effect of octamer mutations on establishment and maintenance of the maternal 
hypomethylation imprint in a knock-in mouse model.  Oct motifs were required for 
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protection of the maternal ICR from de novo methylation in somatic tissue and oocytes 
but are not essential for imprint establishment or mono-allelic expression of H19 and 
Igf2.  
 
RESULTS 
 
CTCF and octamer sites regulated ICR DNA methylation in F9 cells   
The mouse Igf2/H19 ICR has four CTCF sites and a closely spaced pair of 
octamers (Oct sites Intro) that lie about 200 bases from CTCF site 2 (Fig. 1 A). Results 
from mouse and cell culture experiments indicated that CTCF and octamer sites 
separately regulate CpG methylation of the ICR.  Given the importance of the octamer 
pair, we searched for similar sequences in the ICR and found an additional consensus 
octamer site 450bp upstream of CTCF site 1. To determine whether these three sites 
cooperate in regulating ICR methylation, we mutated the elements and assessed the 
methylation status of stably transfected ICR-containing plasmids.  The plasmids were 
stably integrated into F9 embryonic carcinoma cells, as these cells have demonstrated 
both de novo methylation and demethylation of transgenes.  Using methylation sensitive 
Southern analysis, we found that integrated transgenes containing the wild type ICR and 
H19 promoter did not acquire methylation, while mutation of both octamers resulted in a 
small amount of de novo ICR methylation (Fig. 2 A and B).  In contrast to results seen in 
mice, mutation of the four CTCF sites did not lead to increased methylation of the ICR. 
The protective activity of CTCF was apparent only when both the CTCF and octamer 
sites were mutated, as the double mutant ICR showed less digestion by HhaI and HpaII 
than the octamer mutant alone.  
 
In addition to protection from de novo methylation, binding by certain 
transcription factors also can drive demethylation of partially methylated sequences. We 
tested the demethylation activity of the CTCF and octamer sites using stably integrated 
plasmids that had been treated with HhaI and HpaII methyltransferases and found that 
both WT and CTCF mutant ICRs were substantially demethylated (Fig. 2 C), By contrast, 
ICR transgenes with mutant octamers retained most of their partial methylation.  
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Morever, ICR constructs with single mutations in either of the centrally located octamers 
retained methylation to the same degree as the double octamer mutant. Combining CTCF 
and octamer mutations resulted in a modest decrease in demethylation activity (Fig. 2 C). 
Transgenes containing a mutation in only this third octamer showed wild type levels of 
demethylation (Fig. 3 A).  
 
Octamer mediated demethylation of the ICR was both specific to embryonic 
carcinoma cells and limited to ICR constructs with low density methylation. Partially 
methylated WT and mutant ICR transgenes stably integrated into either mouse C2C12 or 
3T3 remained highly methylated (Fig. 3 B). Likewise, WT ICR transgenes fully 
methylated in vitro with SssI methyltransferase also remained highly methylated in F9 
cells (Fig. 3 C).  
 
Sox-Oct motifs regulated ICR methylation in F9 cells  
Octamers often are found adjacent to Sox binding sites, forming a functional Sox-
Oct motif.  We compared the ICR octamers to known Sox-Oct motifs and found potential 
Sox sites flanking each octamer (Fig. 2 A).  We tested the activity of these elements in 
the F9 demethylation assay using partially methylated ICR constructs containing separate 
mutations in the two putative Sox sites (Fig. 2 E). Southern analysis demonstrated a 
moderate reduction in ICR demethylation activity when the Sox site upstream of the 
promoter distal octamer was mutated.  Mutation of the Sox site upstream of the proximal 
octamer exhibited a greater loss in demethylation activity, which was comparable to the 
single octamer mutations. We also identified a sequence 22bp downstream from the 
proximal octamer that bound Sox2 in vitro (Fig. 3 A).  Mutation of this element, 
however, did not effect ICR demethylation alone nor in combination with mutation of the 
first Sox site (Fig. 2 E and Fig. 3 D). 
 
Oct4 and Sox2 bound cooperatively to the ICR Sox-Oct motifs   
F9 cells express Oct4 and Sox2, suggesting that they bind to the Oct-Sox motifs 
in the ICR and mediate demethylation. Consistent with this idea, EMSAs performed with 
F9 nuclear extract showed that both motifs formed heterodimeric complexes with Oct4 
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and Sox2 (Fig. 4 A). Moreover, the same octamer mutations that disrupted ICR 
demethylation also prevented Oct4 binding in vitro (Fig. 4 B). In addition, EMSAs with 
recombinant Oct4 and Sox2 demonstrated that mutations made to the putative Sox sites 
blocked Sox2 binding but did not prevent Oct 4 binding (Fig. 4 C). Because Sox-Oct 
mediated ICR demethylation in F9 cells was limited to partially methylated transgenes, 
we performed EMSAs with ICR probes methylated at CpGs and found that the 
methylation did not inhibit formation of Sox2 and Oct4 heterodimeric complexes (Fig. 3 
C). [The lone Sox binding site identified downstream of the promoter proximal octamer 
also bound to endogenous and recombinant Sox2.]   In vivo binding by Oct4 and Sox2 
was suggested by chromatin immunoprecipitations (ChIP) performed on F9 cell lines that 
showed enrichment for Oct4 and Sox2 at both the endogenous and wild type transgenic 
ICRs, but not at the octamer mutant ICR (Fig. 4 E).  
 
Oct4 and Sox2 often bind DNA cooperatively, and we determined if this occurred 
on the two ICR Sox-Oct elements (Fig. 4 D).  In EMSAs with recombinant proteins, we 
found that Oct4 bound to both elements equally well, but Sox2 alone showed only 
modest binding to the distal element and almost no binding to proximal.  However, in the 
presence of Oct4, Sox2-Oct4 complexes formed with the distal element that 
predominated over either single protein complex, consistent with a cooperative Sox2-
Oct4 interaction.  Similarly, the second (proximal) element also bound Sox2 in the 
presence of Oct4 as demonstrated by the formation of Sox2-Oct4 and the near absence of 
Sox2 complex regardless of the Sox2 concentration. Conserved Sox-Oct motifs in the 
Human ICR A2 repeat (HD1, Hori et al.) also demonstrated cooperative binding of 
recombinant Sox2 and Oct4 in EMSAs (Fig. 5 A).  
 
Given the proximity of the two Sox-Oct sites to one another, we performed 
EMSAs with probes that included both sites to assess whether the dual motifs could 
simultaneously bind two Sox2-Oct4 complexes.  We found that recombinant Oct4 and 
Sox2 were capable of forming two heterodimers on the same WT mouse probe. However, 
this heterotetramer represented a small fraction of observed complexes, and the exact 
binding site of Sox2 in the more abundant heterotrimer was unclear. The formation an 
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Oct4-Sox2-Oct4 specific heterotrimeric complex was observed using a Human ICR A2 
probe with a mutant Sox binding site upstream of the octamer 1 homolog (Fig 5 B).  
 
The ICR Sox-Oct motifs functioned as a transcriptional activator 
 In many cases, the demethylation activity of DNA sequences has been shown to 
correlate with their ability to activate transcription. To determine whether the ICR Sox-
Oct motifs activate transcription, we placed ICR fragments containing the elements 
upstream of a luciferase gene driven by the H19 promoter (Fig. 6 A). In transient 
transfections of F9 cells, the Sox-Oct regions activated the reporters more than five-fold 
compared to the H19 promoter alone. Consistent with their ICR demethylation activity, 
mutation of one or both octamer motifs abolished transactivation and produced a modest 
repression.  Mutations disrupting the cooperative Sox binding sites also abolished 
transcriptional activation, while the lone 3’ Sox motif mutant showed a modest reduction 
in luciferase expression.  To determine if Oct4 was required for transactivation, we 
transfected F9 cells that had been depleted of Oct4 by shRNAs and found that relative 
luciferase expression dropped at least 90% compared to control shRNA expressing cells 
(Fig. 6 B). As an  alternative to Oct 4 knock-down, mouse 3T3 cells lacking endogenous 
Oct4 and Sox2 expression were also transiently transfected with ICR-reporter constructs 
and found to have luciferase levels equal to or less than that of H19 promoter controls 
(data not shown).  
 
Octamers were required for maintenance of the unmethylated maternal ICR in 
somatic cells  
To determine if the octamers participated in establishing or maintaining the ICR’s 
differentially methylated state in vivo, we used homologous recombination and ES cells 
to create mice with mutations in both ICR octamers (Fig. 7 A and B). Southern analysis 
on DNA from neonatal liver and muscle (Fig. 7 C) showed that the loss of octamer 
binding had no effect on the methylation of paternally transmitted mutant ICR's. 
However, methylation of maternally transmitted mutant ICRs increased significantly, as 
indicated by reduced HpaII and HhaI digestion compared to wild-type maternal ICR 
DNA.  The asymmetric distribution of methyl sensitive restriction sites in the probed 
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region also provided a means for assessing the relative location of methylated CpGs.  
Analysis of the banding patterns from 5’ HpaII and 3’ HhaI digests suggests that the 
majority of mutant allele methylation was concentrated near the octamers while the 
region including the promoter proximal CTCF sites was largely unmethylated. To more 
accurately characterize the increased methylation, we performed bisulfite sequencing of 
the region including CTCF site 2 and the octamers from neonatal liver. Previously 
published bisulfite analysis of maternal alleles from somatic tissue had indicated that 
CpGs located near the octamers were more likely to acquire methylation than upstream 
sequences including CTCF site 2 [130]. Consistent with those results we found that the 3 
CpGs within 7bp of the WT maternal octamers were 41% methylated, despite a less than 
15% total methylation for all CpGs assayed (Fig.8 A). In contrast, the maternally 
inherited mutant alleles were 78-93% methylated at all CpGs within 35bps of the 
octamers and more than 53% for all CpGs assayed.  Two CpGs in particular, located 
35bps upstream and 5bp downstream of the first octamer, had 78% and 72% respective 
increases in methylation.  The three CpGs within CTCF site 2 showed a modest 28-35% 
methylation for octamer mutant alleles compared to maternal wild-type alleles (12-23%). 
A comparison of WT and mutant maternal alleles from neonatal muscle yielded similar 
results (Fig. 9). Additional bisulfite analysis of the ICR region proximal to the H19 
promoter from neonatal liver showed vertically no methylation of maternal mutant alleles 
- consistent with the Southern results (Fig. 8 A). Paternal methylation imprints were like 
wise unaffected by the octamer mutations (Fig. 8 A. and data not shown). 
 
Octamer mutations increased methylation in oocytes but not blastocysts 
Methylation of the mutant maternal ICR appeared stable and was relatively 
unchanged from methylation patterns present in somatic tissue from 12dpc embryos (Fig. 
8 B). In order to determine if this methylation pattern was the result of stable inheritance 
from maternal gametes or occurred during embryogenesis, we conducted additional 
bisulfite analysis of maternally derived mutant oocytes and blastocyst (Fig.8 C and D). 
Half of the mutant oocytes sequenced exhibited methylation patterns similar to that of 
somatic tissue while the other half remained unmethylated. Surprisingly, we found the 
ICR of mutant blastocysts to be unmethylated despite the presence of methylation at the 
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ICR of some mutant oocytes indicating the maternal ICR methylation was not to stably 
inherited.  
 
The octamers were not required for establishing an unmethylated ICR in the 
primordial germ line  
We assessed mutant ICR methylation in germ cells during different stages of 
embryogenesis in order to determine if the mutant ICR methylation in oocytes resulted 
from a failure to erase paternal methylation imprints and/or inadequate protection of the 
ICR from de novo methylation during normal gamete imprint establishment. Primordial 
germ cells (PGCs) were isolated from 14, 16 and 18dpc ovaries and testes by crossing 
ICR mutants with a Pou5f1-EGFP strain and FACS sorting the respective dissociated 
tissues. [94-99% of GFP+ FACS isolated cells tested also stained positive for alkaline 
phosphatase (data not shown)]. Bisulfite analysis of PGCs from 14.5 ovary and testes 
showed normal hypomethylation of maternally inherited mutant ICRs (Fig. 10). The ICR 
octamers were not required for erasure of paternal methylation in female PGCs as 
evidenced by the absence of methylation on paternally derived mutant alleles from16dpc 
ovaries. Nor were they required for preventing de novo methylation of the female germ 
line up to and including 18dpc development. In testes, mutant alleles acquired paternal 
specific methylation imprints irrespective of parental origin (Fig. 10). 
 
The ICR octamers had little influence on mono-allelic expression of H19 and Igf2 
 We performed a single nucleotide primer extension assay (SNuPE) in order to 
determine if the methylation observed on the maternal mutant ICR was sufficient to alter 
the normal allelic expression ratios of H19 and Igf2 in liver, muscle, tongue, kidney, and 
brain from neonatal wild type and heterozygous mutant mice. Despite the methylation of 
mutant ICRs in liver and muscle, no significant difference in the ratio of 
maternal/paternal H19 allelic expression was observed for the maternally transmitted 
mutant alleles (Fig. 11 A). The ratio of paternal/maternal Igf2 expression was similarly 
unchanged in all tissues assayed except for kidney where we observed a 2.5 fold decrease 
(p=0.014) (Fig. 8 B). Consistent with normal repression of the maternal Igf2, we 
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observed no difference in size between neonatal mice that inherited the mutant maternal 
allele and their WT litter mates (data not shown). 
 
DISCUSSION 
 
Investigations of the mechanics responsible for mono-allelic expression of 
H19/IGF2 have predominantly focused on methyl sensitive binding of CTCF to the ICR 
and its effect on chromatin architecture. However, the characterization of CTCF as a 
ubiquitous enhancer blocker responsible for modulating chromatin boundaries at 
hundreds if not thousands of diverse loci, means that its binding is unlikely to be 
sufficient for establishing and maintaining the unique differential methylation pattern that 
is a functional requirement of the ICR. Attempts to identify sequence outside of the 
CTCF sites capable of influencing ICR methylation in vivo have been largely 
unsuccessful. In this study we demonstrated that conserved sox-oct motifs within the ICR 
were more influential than CTCF sites in insuring the hypomethylation of transgenes in 
F9 cells. Moreover, the extent of ICR methylation maintained by octamer mutants 
indicated a low degree of functional redundancy between the octamers and CTCF sites 
with respect to sequence-directed demethylation. We also showed that robust octamer-
dependent ICR demethylation required two sox-oct motifs capable of cooperatively 
binding Sox2 and Oct4. This unique double sox-oct motif formed a single functional unit 
capable of driving demethylation or transcriptional activation in cells expressing Oct4 
and Sox2.  Oct1, which was ubiquitously expressed in all cells assayed, was insufficient 
to induce ICR transgene demethylation in non-embryonic carcinoma cells or octamer 
dependent transcriptional activation in F9 cells following knock-down of Oct4 by 
shRNA.  
 
These findings in conjunction with the expression profile of Oct4 and Sox2 during 
early embryogenesis and germ cell maturation suggested the octamer sequences could 
play an essential role in establishing and maintaining the maternal ICR hypomethylation 
imprint in vivo. To test this hypothesis, we created a mouse with mutations at the three 
know octamer sites associated with the ICR and observed the effect of these changes on 
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ICR methylation and allelic expression profiles of Igf2 and H19. In somatic tissue we 
found the region centered at the mutant octamer pair to be hypermethylated on the 
maternally transmitted alleles. This methylation extended to CTCF site 2 on 33% of 
sequenced mutant alleles but did not extend as far as CTCF site 4. In contrast, maternal 
transmission of an ICR with mutant CTCF sites resulted in methylation of nearly 64% of 
CpGs at CTCF site 2 in addition to significant methylation of the 3’ region of the ICR 
including CTCF site 4 [106]. Ectopic methylation for both octamer and CTCF mutants 
was absent from maternal alleles during the blastocyst stage indicating that both motifs 
are required, but insufficient, to prevent de novo methylation of the maternal ICR during 
post-implantation associated cellular differentiation. Lack of methylation at regions of the 
ICR distal to the mutant octamers could be the result of CTCF forming boundaries that 
block the spread of methylation  and/or actively facilitating a euchromatic  architecture 
either through direct interaction with chromatin remodelers such as CHD8 or indirectly 
by mediating interaction with distal enhancers [46,57]. The demethylation of mutant 
paternal ICRs that exhibit methylation independent binding of CTCF during pre- and 
post-implantation embryogenesis supports a more active role for CTCF in regulating ICR 
methylation [28].  
 
  With the exception of WT ICR methylation in oocytes depleted of CTCF [31], 
CTCF binding has proven unnecessary for both erasure of paternal methylation imprints 
and protection of the ICR from methylation in female germ cells [106,123] However,  
Lee and Sing et al. have implicated CTCF binding at the maternal ICR to delayed 
methylation imprint establishment in male PGCs [65]. Here we showed that octamers are 
also nonessential for germ cell erasure of imprints but are necessary for preventing de 
novo methylation of the ICR during post-natal oocyte maturation. Although mutant ICR 
methylation in oocytes did not represent a stable imprint, its acquisition coincided with 
increased Dnmt3L methyltransferase expression and normal maternal methylation 
imprint establishment [14]. In addition, the absence of a significant difference in ICR 
methylation between maternally inherited mutant alleles and WT paternal alleles in 
16dpc testicular PGCs, suggests the ability of octamers to prevent methylation may also 
contribute to a delayed paternal imprint establishment. 
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Protecting maternal hypomethylation imprints may be a common function of Oct4 
and Sox2 at imprinted loci. Similar to the mutant H19/Igf2 ICR, the normally 
hypomethylated human Angelman Syndrome – imprinting center (AS-IC) acquires 
methylation in mouse oocytes when a mutation is made to one of two Oct binding sites or 
an independent Sox site [55]. At both loci oocyte methylation occurs on only a fraction of 
mutant alleles and is lost during fertilization.  Although the individual Oct and Sox sites 
are distributed over a 370bp region of AS-IC and separated by two additional trans-factor 
binding sites, the observation that all three sites are required for in vivo regulation of 
methylation is consistent with our in vitro functional analysis of the two ICR Sox-Oct 
motifs.  
 
Methylation of the mutant maternal ICR may depend on an additional cis-
regulatory element located within 100-200bps of the mutant octamer pair. Surprisingly, 
mice possessing a ~0.9kb deletion of the ICR between CTCF sites 2 and 3, which 
includes the octamer pair, showed increased expression of H19 from the paternally 
inherited mutant allele but no acquisition of methylation at maternally inherited mutant 
ICR [43]. This discrepancy in maternal ICR methylation between mice with octamer 
point mutations verses an octamer inclusive deletion could be explained by the existence 
of an as yet unidentified repressive element located between the octamer and neighboring 
CTCF site(s). Therefore, the function of WT octamers would be, at least in part, the 
inhibition of putative repressor(s) at the maternal ICR. Consistent with this possibility, 
we observed that luciferase reporters containing an octamer mutation in the context of a 
352bp ICR fragment averaged a near 2 fold reduction in luciferase expression compared 
to the H19 promoter alone (Fig. 6 A, standard dev. = 0.5).  
 
Maternal transmission of either a single point mutation or a deletion effecting one 
of the octamers in repeat A2 of the human ICR have been implicated in five different 
cases of Beckwith-Wiedemann Syndrome (BWS)[25,97]. The mouse model presented 
here provides the first direct evidence that maternal transmission of octamer mutations 
alone can result in loss of differential methylation at the ICR. In contrast to BWS cases, 
we observed that mutant octamer induced methylation was mostly absent from the 
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CTCF-sites of maternally inherited alleles and consequently imprinted expression of H19 
and Igf2 was unaffected. These results suggest that the extent to which conserved 
octamers control ICR methylation may depend on non-conserved aspects of ICR 
architecture and/ or species specific developmental modalities. The existence of unique 
species requirements for maintenance of differential methylation at the H19 and Igf2 
locus was previously reflected in the inability of human ICR transgenes to maintain 
methylation acquired in the male germ line throughout mouse embryogenesis [49]. 
Further studies are needed to determine whether conserved octamers regulate mouse and 
human ICR methylation through a common mechanism including the potential 
modulation of neighboring repressive elements.  
 
METHODS 
 
Plasmid construction 
Octamer and Sox site mutations were inserted into the WT and CTCF mutant ICR 
using fragments created by overlapping PCR with mutant primers.  Substitutions at 
octamers 2 and 3 (-3248 and -4338 with respect to the H19 start site) created novel BspHI 
sites. The 1.5kb mutant PCR products were ligated into the XhoI and BspEI sites of a 
pcDNA3-luciferase vector containing the mouse H19 upstream region (from -5547 to 
+695) with either WT or mutant CTCF sites.  WT and mutant Sox constructs were 
prepared by replacing the octamer region from -3305 to -3209 in the same pcDNA vector 
containing the mouse H19 upstream region with a unique SpeI site via overlapping PCR. 
WT and mutant 83bp sequences corresponding to the deleted region and possessing 5’-
CTAG overhangs were constructed by ligating three double-strand oligonucleotides 
containing the appropriate mutations were then ligated to a SpeI linearized vector. (See 
EMSA probes in Table 1 for WT and mutant sequences.)  
 
Luciferase reporter constructs were prepared by inserting either a 352bp WT or 
mutant octamer PCR product (-3396 to -3044) or the 83bp WT or mutant Sox sequence 
into the NheI site of the pH19-Luc vector [57]. All PCR-derived constructs were 
sequenced to ensure fidelity.    
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Oct4 and Sox2 recombinant protein expression vectors were prepared by cloning 
BamHI – SalI fragments containing the respective cDNAs from pMXS-Oct3/4 and 
pMXS-Sox2 [Addgene plasmids  13366 and 13367[124]] into the BamHI site of pET-15b 
(Novagen).          
 
We prepared the mutant octamer knock-in vector by ligating the mutant ICR 
contained within an XbaI fragment from -5.5 to -0.8kb between the lox511 and loxP sites 
of a previously described targeting vector[106].  
 
Cell culture, transfection, luciferase assays, and Oct4 knock-down 
F9, 3T3, and C2C12 cells were cultured in Dulbecco's modified Eagle's medium 
(DMEM) supplemented with 10% fetal bovine serum (FBS) and penicillin-streptomycin. 
F9 cells were cultured on 0.1% gelatin-coated dishes.  For ICR methylation analysis, 
partially methylated constructs were treatment with HhaI and HpaII methyltransferases. 
The fully methylated WT ICR construct was in vitro methylated with SssI methyl 
transferase.  Complete methylation was verified by HhaI and HpaII restriction digest 
followed by agarose gel electrophoresis and ethidium bromide staining. Only DNA 
showing no digestion was used in transfections.  Cells were co-transfected with test 
constructs and either a pcDNA3.1 or pBS-puromycin selection plasmid at a ratio of 5:1 
using either FuGENE 6 (Roche) or MirusTransIT-LT1 at a lipofectant to plasmid ratio of 
3:1. Cells underwent 10 days of selection with either G418 or puromycin.  Colonies were 
passaged onto 60mm plates and harvested when confluent.  
 
Transient transfections of F9 cells were performed in six well plates using 3 L 
MirusTransIT-LT1 and 0.5 g each of test construct and pSV--gal (Promega). After 48 
hours, cells were harvested in Reporter Lysis Buffer (Promega), and -Galactosidase and 
luciferase activity were assayed as previously described[17]. Relative luciferase 
expression was calculated after normalizing for -galactosidase activity. Student’s t-test 
was used to determine statistical significance of at least three independent transfections.  
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  Knock-down of Oct4 in F9 cells was achieved using lentiviral particles derived 
from Sigma-Aldrich MISSION plasmids pLKO.1, (S1= Clone ID: NM_013633.1-
659s1c1, and S3= Clone ID: NM_013633.1-544s1c1). A pLKO.1 vector with a non-
targeting shRNA (SCR= Addgene plasmid 1864[105]) served as a negative control. 
Lentivirus was produced in 293T cells and used to infect F9 cells on a 6 well plate 
according to the Addgene pLKO.1 Protocol version 1.0 (December 2006). F9 cells 
underwent selection with puromycin from 25-48 hrs post-infection and then were 
passaged onto a 6 well plate. At 72 hrs post-infection, cells were transfected with 
luciferase vectors and pSV--gal and then collected for analysis after 48 hrs. Oct4 knock-
down was verified by Western blotting extracts from cells infected in parallel and 
collected 5 days post-infection using rabbit -Oct4 [Santa Cruz sc-9081 (1:500 dilution)] 
and mouse -nucleophosmin (NPM) [LabVision ms-1849 (1:10,000)]. HRP-conjugated 
human -rabbit IgG [Sigma-Aldrich A0545 (1:5,000)] and goat -mouse IgG [Jackson 
ImmunoResearch 63656 (1:8,000)] secondary antibodies.  Blots were visualized using 
Peirce SuperSignal West Pico Chemiluminescent Substrate.  
 
Southern Blot 
To assess ICR methylation, genomic DNA was purified as previously described 
and digested with BglII followed by HhaI or HpaII methyl-sensitive restriction enzymes 
[106]. MspI, an isoschizomer of HpaII not sensitive to methyl-cytosine, was used as a 
positive control for complete digestion. Digested DNA was separated by agarose gel 
electrophoresis followed by blotting to Hybond-XL (Amersham Biosciences). Probes 
were radiolabeled with the Takara Random Primer DNA Labeling Kit and hybridized to 
membranes in either Rapid-Hybe Buffer (GE Healthcare) supplemented with 25 g/ml 
salmon sperm (SS)DNA at 65 °C for 2hrs or 3% Poly(acrylic acid)pH8.0, 6x SSPE, 1% 
SDS, 0.1% BSA, 25ug/ml SS DNA at 65 °C overnight. After hybridization membranes 
were washed in 2x SSC, 0.1% SDS at room temperature for 2 min, twice in 1x SSC, 
0.1% SDS at 65 °C for 15 min, and once in 0.1x SSC, 0.1% SDS at 65 °C for 30 min. 
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Electrophoretic mobility shift assays 
F9 nuclear extract (NE) was prepared as previously described [107]. Recombinant 
Oct4 and Sox 2 were purified from IPTG induced Rosetta (DE3) pLys competent cells 
(Novagen) transformed with pET-15b-Oct4 or pET-15b-Sox2 expression vectors and 
cultured in LB supplemented with ampicillin and chloramphenicol. After lysis with 
BugBuster Protein Extraction Reagent (Novagen), Oct4 and Sox2 were purified from 
inclusion bodies by preparative SDS-polyacrylamide gel electrophoresis.  Isolation and 
renaturation of the gel-isolated proteins were performed according to Hager and Burgess 
[37]. 
 
  Oligonucleotide probes and competitors used in EMSA are listed in the 
Supplementary material, Table S1. For each reaction 25 fmoles of labeled double-
stranded probe was incubated for 10 min at room temperature with either F9 NE or 
recombinant Oct4 and/or Sox2 proteins in a 16 l reaction buffer containing 10mM Tris 
pH8.0, 2 mM MgCl, 100mM KCl, 1.25 mM DTT, 5% glycerol, 0.0625% BSA, and 19 
g/ml dGdC.  Supershifts included an additional 10 min RT incubation with 1 g of anti-
Oct4 (Santa Cruz sc-9081), anti-Sox2 (Santa Cruz sc-20088), or IgG (Santa Cruz sc-
2028) as a negative control. Reactions were separated on a 4% 0.25X TBE 
polyacrylamide gel at room temperature, which was dried before exposing to film.   
 
Chromatin immunoprecipitations (ChIP) 
Chromatin from F9 and F9 mutant ICR stable transfectants was prepared and 
immunoprecipitated using the ChIP-IT Express kit (Active Motif). Chromatin was cross-
linked at room temperature with either 1% formaldehyde for 10 min or 2 mM 
disuccinimidyl glutarate (DSG) 45min followed by formaldehyde for 10 min (Sox2 
endogenous ICR precipitations only) and sonicated using a Vibra Cell (VC 375) 
ultrasonic processor.  Each ChIP reaction contained 25 g of sheared chromatin 
precipitated with 6ug anti-Oct4 (Santa Cruz sc-9081), 6 g anti-Sox2 (3 g each of Santa 
Cruz sc-20088 and sc-17320) or 6 g IgG (Santa Cruz sc-2028 and sc-2027) as a 
negative control. Precipitated DNA was analyzed using a two-step qRT-PCR reaction in 
SsoFast EvaGreen Supermix (Bio Rad) on a Bio Rad iCycler. The octamer region of the 
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ICR was amplified using the following primer set: 5’-ATGCAGACCCCACTAAGCAT-
3’ AND 5’-CGGAGATCATTAGCATCTGA-3’.  
 
Generation of transgenic mice 
ES cell lines and chimeric mice were created by the University of Illinois 
Transgenic Mouse Facility. CJ7 cells were electroporated with SalI linearized knock-in 
vector and colonies were selected for G418-resistance. ES clones demonstrating proper 
targeting by Southern analysis were injected into C57BL/6J (B6) derived blastocysts. 
Genotyping and confirmation of Cre-mediated deletion of the neo cassette were 
performed by Southern analysis and PCR of tail DNA (MOPrimer, 5’- 
ATCATTGGGGCGTTCAGATAATC-3’ AND OCR3, 5’-GACAGTGCAAAA-
CAGGTGAA-3’). All animal experiments in this study followed protocols approved by 
the Animal Care and Use Committee at the University of Illinois at Urbana-Champaign. 
  
Germ cell isolation  
Embryos for PGC isolation were obtained from matings between mutant ICR 
mice and B6;CBA-Tg (Pou5f1-EGFP) [122]. Embryos were sexed and staged according 
to morphology [126]. Embryonic gonads were separated from the mesonephros, digested 
with 150 l of trypsin-EDTA [0.2% trypsin, 1 mM EDTA, 1× phosphate-buffered saline 
(PBS)] for 15min at 37°C, washed with DMEM supplemented with 10% fetal bovine 
serum and manually triturated to a single cell suspension using a 1 ml syringe and 30G 
needle. GFP positive cells were isolated by flow cytometry on a BD Biosciences LSR II. 
PGC purity was verified by assaying for alkaline phosphatase activity using the Vector 
Blue Phosphatase Substrate Kit III (Vector Laboratories).  
 
Bisulfite sequencing 
Genomic DNA from PGCs, oocytes, and blasts was prepared and bisulfite treated 
using the EZ DNA Methylation-Direct Kit (Zymo Research) according to the 
manufacturer’s instructions. Genomic DNA from neonatal liver and muscle was prepared 
separately and added directly to the conversion reagent [106]. Primers (Bi3000F and 
Bi3455R) and PCR conditions for amplification of CTCF site 4 were as previously 
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described [106]. Amplification of CTCF site 2 and the octamer region were performed 
using the following primer set:  Bi1825F, 5’-TTGTAAA-
GAATTTTTTGTGTGTAAAG-3’ and Bi2310R, 5’-
ATACAATTTCAAAATTATTTACAA-CCC-3’ and 35-40 cycles of PCR under the 
following conditions: 95 °C, 30 s; 52 °C  40 s; 72 °C, 100 s. For oocytes a secondary 
PCR with 1-5 l of the first reaction was performed for 35 cycles with the same 
parameters. PCR products were gel-purified and cloned following the manufacture’s 
protocol (pGEM-T, Promega).  
 
RNA isolation and SNuPE analysis  
Tissue was dissected from WT and mutant 4 day old pups obtained from mating 
female mice heterozygous for the mutant ICR with males that were homozygous for the 
M. casteneus Igf2/H19 locus. RNA was purified using the RNeasy Mini Kit (Qiagen), 
and all samples were subjected to on-column DNase digestion (RNase-Free DNase Set, 
Qiagen). Tissue was homogenized for 3 min in RLT buffer using 0.1mm Zirconia/Silica 
beads and a Mini-BeadBeater (Biospecs Products). Igf2 and H19 transcripts were 
amplified by using the SuperScript First Strand Synthesis System (Invitrogen), the 
following primer sets: Igf2-168F/U, 5’- ACGTGTCTACCTCTCAGGCCGTACT-3’ and 
Igf2-166R, 5’-GGGTTGTTTAGAGCCAA-TCAA-3’ [121]; H19-172F, 5’-GCACTAA-
GTCGATTGCACTGG-3’and H19-172R, 5’-GCCTCAAGCACACGGCCACA-3’ [118], 
and 35 cycles of PCR under the following  conditions: (Igf2) 95 °C, 20 s; 53 °C  20 s; 72 
°C, 30 s; and (H19) 95 °C, 20 s; 56 °C  20 s; 72 °C, 20 s. Control reactions lacking RT 
did not yield a PCR product. SNuPE was performed as previously described [112] using 
the following primers: Igf2-169R/S, 5’-TCAAATTTGGTTT-TTTAGAA-3’ [121]; H19-
173R/S, 5’-GGCAGCATTGCCAAAGAGG-3’[118]. Quantification of SNuPE reactions 
following electrophoresis was performed using a Storm 860 Phosphoimager and 
ImageQuant 5.2 software.                                         
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FIGURES AND TABLES 
 
                       
Figure 2. Analysis of ICR transgene methylation in F9 cells. (A) Structural map of ICR construct 
depicting CTCF (white oval), octamers (shaded oval), restriction enzymes BglII (B), HhaI, (dark grey bar), 
HpaII (light grey bar). Octamers 1 and 2, (ICR sox/oct 1 and 2 respectively), are compared to the consensus 
sox2-oct4 motif. Southern-blots are shown for stably incorporated WT (wt) or mutant ICR constructs which 
were either in vitro unmodified (B) or in vitro partially methylated with HhaI and HpaII methyltransferases 
prior to transfection(C-E). Mutations to the ICR transgenes include: disruption of the 4 CTCF sites (mut 
ctcf), the three octamer sites (mut oct), both octamer and CTCF sites (mut oct & ctcf); either the first or 
second octamer site (mut oct 1 and mut oct 2, respectively) alone (wt ctcf) or in combination with CTCF 
mutations; and the replacement of an 83 bp region including the octamer pair with a either a modified WT 
sequence (wt sox), or mutations to the 5’ flanking sequence of the first octamer (mut sox 1), the sequence 
between the octamer pair (mut sox 2), or the 3’ flanking sequence of the second octamer. All genomic DNA 
was digested with BglII alone or in combination with HhaI (H), HpaII (P), or MspI (M) as a positive control 
for HpaII. For Southern hybridization, DNA was probed with the 2.4kb BglII fragment. 
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 Figure 3. Analysis of WT and mutant ICR transgene demethylation in F9, C2C12, and 3T3 mouse 
cell lines via methylation sensitive Southern-blot. ICR constructs as described in figure 1 or with 
mutations to octamer 3 or sox sites 1 and 3 were either in vitro partially methylated and stably incorporated 
into F9 cells (A and D), C2C12 cells, or 3T3 cells (B) or fully methylated and stably incorporated into F9 
cells (C). 
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Figure 4. Sox2 and Oct4 binding at the ICR. EMSAs were performed using labeled WT or mutant ICR 
sox-oct motifs ( 1 and 2) or a 3’ sox site down-stream of the second octamer (3). Oct 4 and Sox 2 specific 
binding was assessed using F9 NE (A,B) or recombinant Oct4 and Sox2 (C,D). (A) Sox2 and Oct4 protein-
DNA complexes (white and black triangles respectively) were identified by the addition of antibodies (Ab). 
Oct 1 complexes are indicated by a grey triangle. (B)The effect of octamer specific point mutations on Oct4 
and Sox2 binding was assessed by addition of unlabeled nonspecific (N), Oct 4 specific (O), Sox2 specific 
(S), wild type ICR sox-oct 1 and 2, or ICR octamer 1 and 2 mutant (M1 and M2) competitors. (C) ICR 
probes with mutations at the respective upstream and downstream octamer flanking sequences (mut1, mut2, 
and mut3) or CpG methylation (1c and 2c) were used to validate disruption of Sox 2 binding. (D) 
Cooperative binding characteristics of Oct 4 and Sox 2 at the ICR were assessed by comparison of Sox2 
binary and Oct4-Sox2 ternary protein-DNA complexes formed using a fixed amount of Oct 4 and increasing 
amounts of Sox2. See supplemental table I for a complete list of EMSA oligonucleotides. (E) Enrichment of 
endogenous F9 or wt and mut transgenic ICR octamers by Oct 4 and Sox2 ChIP was determined by QRT-
PCR and normalized to serum controls. Statistical significance of enrichments for Oct 4 and Sox 2 at the 
endogenous locus according to the t.test (n=3) are p=0.05 and p=0.047 respectively. Error bars represent 
standard deviation of the mean. 
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Figure 5. EMSAs with WT octamer probes for the human and mouse ICR conducted with 
recombinant Oct4 and Sox2. (A) Probes containing conserved sox/oct motifs from the Human ICR A2 
repeat were incubated with Sox2 and increasing amounts of Oct4. (B) Probes containing the complete 
mouse ICR double sox/oct motif or the first octamer and the second sox/oct motif of the Human A2 repeat 
were incubated  with Sox2 and increasing amounts of Oct4. Probe sequences are located in supplemental 
table I. 
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Figure 6. ICR sox-oct motifs function as Oct-4 and Sox-2 dependent transcriptional activators. F9 
cells were co-transfected with a β-gal. reporter and constructs containing a luciferase report driven by the 
H19 promoter alone or in combination with either a 352bp or an 83bp upstream ICR fragment. (A) 
Transcriptional activation is shown as the total luciferase activity normalized to b-gal and H19 promoter 
luciferase expression. Mutations disrupting Oct 4 binding to either octamer 1 (MO1), octamer 2(MO2) or 
both octamers (MO3) were part of a 352bp ICR fragment. Mutations disrupting Sox 2 binding upstream of 
octamer 1 (MS1), upstream and downstream of octamer 2 (MS2 and MS3 respectively) were part of an 
83bp ICR fragment.  (B) The effect of Oct 4 shRNA knock-down on relative luciferase activity is shown 
for constructs containing either two copies of the wt 83bp ICR fragment (wt 83x2) or the wt 352bp 
fragment. Average relative luciferase activities for F9 cells infected with the shRNA negative control 
(SCR) and transiently transfected with wt 83x2 or wt 352 were 39.7 and 6.9 (standard dev. = 10.3 and 3.1) 
respectively. ‘O4 shRNA’ includes both S1 and S3 shRNA sample populations. Western blot with F9 CE 
from Oct4 #1, Oct4 #3, or SCR treated cells probed with -Oct-4 and -NPM antibodies.  
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Figure 7. Targeting of the three octamer mutations in ES cells and methyl sensitive Southern 
analysis of somatic tissue from knock-in mice. (A) In top-down order are the H19/Igf2 locus, the targeting 
vector, and the targeted locus. The neomycin resistance (neo
r
) and Cre recombinase (cre) genes were 
removed in the germ line of male chimeras by testes-specific expression of Cre. Restriction sites are AseI 
(A), BamHI (B), EcorV (E), NdeI (N), and SalI (S). (B) Southern-blot analysis to confirm targeting of the 
mutant ICR (M.ICR) was carried out on EcorV –digested WT and targeted ES cell DNA hybridized to a 
probe that lies 5’ of the targeting arm or on NdeI-digested DNA hybridized to a probe 3’ of the targeting 
vector. Correct Cre-mediated excision of the selection cassette was confirmed by BamHI and AseI-digested 
tail DNA from F1 mice. (C) Southern analysis of maternally and paternally inherited WT and mutant ICR 
neonatal liver and muscle. DNA were digested with BsphI (Bs) and then HhaI (H), HpaII (P), or MspI (M). 
The mutation in the promoter proximal octamer creates an additional BsphI (Bs*) restriction site. The 1.4kb 
mutant ICR fragment was used for the probe.    
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Figure 8.  Bisulfite sequencing of WT and mutant ICRs. Each horizontal line represents an 
independent sequence. Unmethylated and methylated CpGs are presented as open and closed circles, 
respectively. Multiple occurrences of the same pattern are indicated to the right of each sequence. Lines 
above the circles indicate relative location of CTCF and Oct sites. The mutant status and the allelic parent 
of origin are indicated to the upper left of each block of sequences. PCR products were obtained from (A) 
the neonatal liver DNA of heterozygous 4 day old mice with maternally WT, maternally mutant, or 
paternally mutant transmitted ICRs and (B) maternally transmitted mutant alleles from 12dpc embryonic 
liver.  (C)  WT and mutant bisulfite products from oocytes were the result of separate PCR reactions each 
using the DNA from 10-20 oocytes. Each reaction product was cloned separately, and 3-6 clones of each 
product were sequenced. Identical sequences from each reaction were counted only once. (D) For 
blastocysts, two separate PCR reactions were performed each using the DNA from 6-10 bastocysts. Each 
product was cloned separately and considered to be unique. 
 
36 
 
                           
Figure 9.  Bisulfite analysis of WT and mutant ICRs from transgenic mice. (A)Bisulfite sequencing 
of muscle from 4 dpn pups generated from the cross of a female with a mutant ICR and a father with a WT 
castaneous ICR (B) Bisulfite sequences for PGCs from 18 dpc testes with paternally inherited mutant allele 
and a maternally inherited WT allele. 
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Figure 10.  Methylation profile of WT and mutant ICRs from female and male germ cells. Bisulfite 
sequencing of the CTCF 2 and octamer region are shown for germ cells isolated from 14, 16, and 18dpc 
ovaries and testes. Each block of bisulfite sequences was the result of 1-2 separate PCR reactions 
performed with DNA from 1x10
3
-1x10
4
 pooled germ cells. All products were cloned separately and 
considered to be unique. See figure 5 for other details. 
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Figure 11.  Allelic H19 and Igf2 mRNA expression ratios in neonatal mice. SNuPE analysis was 
carried out on (A) H19 and (B) Igf2 cDNA from 4dpn heterozygous mice having a paternally inherited 
WT castanious allele and a maternally inherited WT or mutant B6 allele. The ratio of transcript for each 
tissue was determined by averaging the individual allelic ratios for 3-5 different mice. Error bars 
represent the standard deviation of the mean. The p value for the kidney Igf2 transcript ratio was 
generated using the t.test (n=8).  
 
39 
 
 
 
Table 1. EMSA oligonucleotides. Only the top strand of each dsDNA probe or competitor is provided. 
Mouse and human sequence positions correspond to AF049091 and AF125183 respectively. Changes made 
to the reference sequences are underlined. Lowercase sequence was added for cloning. 
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CHAPTER 3: CONCLUSION 
 
At the time this project was begun in 2002, little was known about the cis-
regulatory elements governing ICR methylation.  At the H19/Igf2 locus only CTCF 
binding sites had been proven necessary for preventing de novo methylation of the 
maternal ICR during embryogenesis, and no cis-elements were known to be required for 
establishment of differential methylation patterns in PGCs [106]. In August of 2002 
conserved octamer sites at the ICR were found to be necessary for both preventing de 
novo methylation and promoting demethylation of ICR transgenes in tissue culture [42]. 
Despite the implications for octamers in regulating imprint establishment and 
maintenance and the relative lack of alternative candidates, a direct assessment of 
octamer involvement in imprinting was not published for more than seven years. In 2009 
Oct and Sox sites at the human PWs/AS locus were found to be required for protecting the 
human ICR on an exogenous transgene from de novo methylation in mouse oocytes [55] 
Furthermore, methylation of the mutant transgenes correlated with loss of imprinting. 
More recently maternal inheritance of mutations disrupting octamers at the human 
H19/Igf2 ICR has been associated with maternal ICR methylation and loss of imprinting 
in BWS patients [25,97].       
    
Given the importance of CTCF in regulating the mouse ICR, this project began by 
comparing the effect of octamer and CTCF site mutation on ICR methylation in order to 
determine if they have synergistic or redundant functions. Utilizing a murine tissue 
culture based system we discovered that octamers were the primary regulator of ICR 
transgene methylation and that CTCF had only a modest additive effect on protecting and 
removing methylation from stably incorporated plasmids. These results are particularly 
important in light of recent findings that Oct4 contributes to X-chromosome pairing and 
counting in part through the formation of a complex with CTCF and other proteins [26]. 
From their position 350bp downstream of CTCF site 2 and 600bp upstream of CTCF site 
3 the two ICR octamers could potentially influence ICR methylation by regulating the 
binding of CTCF. However, our results indicate octamer and CTCF sites function 
independently.  
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Because the adjacent sequences and unique relative spacing of the two octamers 
was highly conserved between human and mouse, we tested additional constructs with 
separate mutations at either a single octamer or its respective 3’ or 5’ flanking sequences. 
We discovered that mutation of only one octamers or the sequence that links them 
resulted in a loss of demethylation activity equivalent to that of a double octamer mutant 
indicating that these three regions function as a single regulatory element. EMSA 
confirmed the presence of Sox2 binding sites upstream of each octamer and the 
cooperative binding of Sox2 and Oct4 to each respective dual motif. This double Sox/Oct 
motif also functioned as a single element capable of inducing transcriptional activation. 
Mutation of any one Sox or Oct biding site resulted in a complete loss of luciferase 
reporter activation. Moreover, both DNA demethylation and transcriptional activation 
were specific to F9 cells expressing Oct4 and Sox2. 
 
The mechanism by which Oct4 and Sox2 influence ICR methylation is unclear, 
but the F9 tissue culture system used here could continue to serve as a valuable tool for 
future studies. Using shRNA we were able to successfully knock-down Oct4 for short 
periods in order to test its necessity for transcriptional activation. A modified approach 
could be used to test the necessity of trans-factors associated with active demethylation 
such as the TET family of proteins, AID, or members of the BER pathway [35,38,98]. 
Alternatively, one could complete the same demethylation experiments but utilize an 
assay sensitive to 5hmC. We also did not address the possibility that the Sox-Oct motifs 
may function through transcriptional activation of an unidentified local promoter. This 
possibility could be explored by searching for enrichment of ICR ncRNAs in F9 stable 
transfectants.  
 
A similar system could also be used to assess requirements for maintaining ICR 
methylation. In our studies only partially methylated constructs were demethylated while 
fully methylated constructs remained methylated despite the methylation independent 
binding characteristics of Oct4 and Sox2. This result is consistent with the observation 
that paternal methylation imprints in somatic cells generally remain stable even during 
Oct4- and Sox2- mediated genome wide reprogramming associated with creation of 
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induced pluripotent stem (IPS) cells [96]. Mutation of putative Zfp57 binding sites on 
methylated ICR constructs or knock-down of ZfP57 and/or its associated partners, KAP1, 
UHRF1 and SETDB1, and other MBDs could be used to investigate their respective 
contribution to maintaining ICR methylation [99,149]. 
 
 To ascertain if the octamers are directly involved in establishing and maintaining 
H19/Igf2 imprints we created a knock-in mouse possessing octamer mutations at the 
endogenous ICR. These mice demonstrated normal paternal methylation imprints but 
abnormal acquisition of methylation on the maternal allele in somatic tissue and oocytes. 
Maternal ICR methylation was concentrated at the region nearest the octamers and 
extended as far as the nearest upstream CTCF site. However, the methylation had little 
effect on maternal imprinted expression of H19 and Igf2 and the mice were 
phenotypically normal. Moreover, the methylation observed in oocytes was erased in the 
blastocyst stage and therefore did not constitute a stable imprint.  
 
 This work documents the first instance of endogenous Sox-Oct motifs being 
required for differential methylation of a mouse ICR. The pattern and temporal 
distribution of methylation observed provides important insights into the state of the ICR 
during gametogenesis and early development. Oct4 is expressed in PGCs during imprint 
erasure but we show here that it is not required for erasing methylation at the paternal 
H19 ICR. However, Oct4 present during the establishment of methylation imprints in 
male PGCs may contribute to the characteristically slower rate of methylation observed 
on the maternal allele [22,65]. We observed a modest increase in the amount of mutant 
maternal ICR methylation in 16 dpc male PGCs compared to the WT alleles from the 
same embryo population indicating that Oct4 may have a protective effect at the ICR that 
must be overcome in the male germ line. This result was similar to what has been 
observed for PGCs with CTCF site mutations [65]. 
 
 The de novo methylation of the region surrounding the mutant octamers could be 
explained by the active recruitment of methyltransferases. Modest bi-allelic expression of 
H19 in mice that have inherited a paternal deletion of the sequence between CTCF site 2 
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and 3 suggests a repressive cis-regulatory element may exist in the octamer region [43]. 
However, deletion of the region did not effect ICR methylation so the mechanism 
responsible for H19 repression is unclear. Because the octamers were also removed, a 
modal in which Sox-Oct motifs regulate the activity of a putative repressive element 
capable of initiating de novo methylation is consistent with both our findings.     
 
  The mechanism by which CTCF regulates overall ICR methylation and 
contributes to the localized methylation pattern of octamer mutants is unknown. The 
binding of CTCF to the unmethylated mutant ICR in both late stage oocytes and the 
developing embryo may be capable of establishing a defined chromatin boundary that 
restricts the spread of methylation to the rest of the ICR. Alternatively, CTCF may 
actively block de novo methylation by promoting euchromatic histone modifications [39]. 
Whether histone modifying complexes are recruited directly by interacting CTCF 
activation domains or through the activity of enhancers tethered to the ICR by CTCF 
dependent intra-chromosomal loops is unclear [57]. The latter hypothesis is enticing 
because it places the centrally located octamers at the putative transition point between a 
repressive loop containing Igf2 and an active loop containing H19. In this model the ICR 
would be split into two CTCF binding domains, each with two CTCF binding sites, 
joined by a 1 KB linker region containing the octamer sites. Interactions between the two 
ICR domains, DMR1 and MAR3 would result in a small loop or partition of the linker 
region and its methylated state would be governed by its own cis-regulatory elements 
(Fig 12). Mutations to either CTCF site 1-3 or only site 4 results in loss of maternal 
imprinting and biallelic expression of Igf2 suggesting independent functions for CTCF 
sites in forming the higher-order chromatin structure normally associated with the 
maternal allele [92,93]. Additional single or double CTCF site mutants are needed to 
ascertain the extent to which sites 1 and 2 and sites 3 and 4 contribute to distinct 
elements. If either CTCF site 2 or 3 were shown to be expendable for maternal 
imprinting, a combination of mutations to both octamer and CTCF sites 2 and 3 could 
shed light on the extent to which these CTCF sites restrict the spread of mutant octamer 
induced methylation.      
44 
 
The different degrees to which mutant ICRs were methylated in oocytes and 
somatic tissue suggests disparate mechanisms exist for preventing de novo ICR 
methylation. In somatic tissue CpGs surrounding the mutant octamers were methylated 
on all alleles indicating a unique role for octamers in maintaining ICR hypomethylation. 
However, in oocytes octamer mutations resulted in methylation on only a fraction of 
alleles suggesting a redundant mechanism may be in place to insure proper imprint 
establishment. One possibility is that CTCF may provide a redundant function in 
protecting the ICR from de novo methylation during oocyte maturation. The complete 
absence of methylation at ICRs lacking CTCF binding in oocytes however, suggests an 
alternative mechanism. Despite elevated Oct4 in oocytes during the time of imprint 
establishment, it is unclear whether octamer sites would be sufficient to insure 
hypomethylation as they are not sufficient for preventing de novo methylation of the 
maternally inherited CTCF mutant ICR during embryogenesis [106,147,148]. A second 
hypothesis is that Oct4 may regulate CTCF mediated chromatin looping in the oocyte by 
antagonizing its interaction with cohesin similar to what has been observed at the HOXA 
locus [56]. CTCF has been suggested to mediate both intra- and inter-chromosomal 
interactions at the H19 ICR [71]. Similar interactions involving the octamer mutant ICR 
in oocytes could lead to sporadic methylation of alleles if the other loci contained cis-
acting repressive elements. Both hypotheses could be tested by creating a mouse with 
ICR mutations at all CTCF and octamer sites as the former would lead to more pervasive 
methylation while the latter should reduce methylation.  
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FIGURE 
 
 
Figure 12. Sox2-Oct4 mediated hypomethylation of the maternal ICR. An expanded view of the 
unmethylated (open lollipops) ICR is shown depicting the role of Sox2 and Oct4 in protecting the 
sequences linking CTCF sites 2 and 3. 
2           3 
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